CD274 and neoplasm: Tumor mutation burden and programmed death receptor ligand‐1 and 1 (PD‐L1 and PD‐1, respectively), as well as the number and percentage of lymphocytes, are biomarkers for the occurrence of metastasis in NSCLC.